Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:25321415 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:26472689 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of PRKAG2-AS1 mRNA | CTD | PMID:25979313 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:27989131 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:27188386 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of PRKAG2-AS1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKAG2-AS1 mRNA | CTD | PMID:27188386 | propofol | decreases expression | EXP | | 6480464 | Propofol results in decreased expression of PRKAG2-AS1 mRNA | CTD | PMID:35238236 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of PRKAG2-AS1 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PRKAG2-AS1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PRKAG2-AS1 mRNA | CTD | PMID:29154799 | |